Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Clinical cancer research

Results: 76-100/3141

Authors: Chakravarti, A Delaney, MA Noll, E Black, PM Loffler, JS Muzikansky, A Dyson, NJ
Citation: A. Chakravarti et al., Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas, CLIN CANC R, 7(8), 2001, pp. 2387-2395

Authors: Schmalfeldt, B Prechtel, D Harting, K Spathe, K Rutke, S Konik, E Fridman, R Berger, U Schmitt, M Kuhn, W Lengyel, E
Citation: B. Schmalfeldt et al., Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer, CLIN CANC R, 7(8), 2001, pp. 2396-2404

Authors: Hata, K Fujiwaki, R Nakayama, K Miyazaki, K
Citation: K. Hata et al., Expression of the Endostatin gene in epithelial ovarian cancer, CLIN CANC R, 7(8), 2001, pp. 2405-2409

Authors: Gong, G DeVries, S Chew, KL Cha, I Ljung, BM Waldman, FM
Citation: G. Gong et al., Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization, CLIN CANC R, 7(8), 2001, pp. 2410-2414

Authors: Thor, AD Edgerton, SM Liu, SQ Moore, DH Kwiatkowski, DJ
Citation: Ad. Thor et al., Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers, CLIN CANC R, 7(8), 2001, pp. 2415-2424

Authors: Grotzer, MA Hogarty, MD Janss, AJ Liu, XY Zhao, HQ Eggert, A Sutton, LN Rorke, LB Brodeur, GM Phillips, PC
Citation: Ma. Grotzer et al., MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma, CLIN CANC R, 7(8), 2001, pp. 2425-2433

Authors: Klauber-DeMore, N Van Zee, KJ Linkov, I Borgen, PI Gerald, WL
Citation: N. Klauber-demore et al., Biological behavior of human breast cancer micrometastases, CLIN CANC R, 7(8), 2001, pp. 2434-2439

Authors: Jimenez, RE Hussain, M Bianco, FJ Vaishampayan, U Tabazcka, P Sakr, WA Pontes, JE Wood, DP Grignon, DJ
Citation: Re. Jimenez et al., Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic significance and comparative analysis in primary and metastatic tumors, CLIN CANC R, 7(8), 2001, pp. 2440-2447

Authors: Konecny, G Untch, M Arboleda, J Wilson, C Kahlert, S Boettcher, B Felber, M Beryt, M Lude, S Hepp, H Slamon, D Pegram, M
Citation: G. Konecny et al., HER-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer, CLIN CANC R, 7(8), 2001, pp. 2448-2457

Authors: Hassan, KA El-Naggar, AK Soria, JC Liu, D Hong, WK Mao, L
Citation: Ka. Hassan et al., Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue, CLIN CANC R, 7(8), 2001, pp. 2458-2462

Authors: Ohta, J Miyoshi, Y Uemura, H Fujinami, K Mikata, K Hosaka, M Tokita, Y Kubota, Y
Citation: J. Ohta et al., Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer, CLIN CANC R, 7(8), 2001, pp. 2463-2467

Authors: Ferreira, CG van der Valk, P Span, SW Ludwig, I Smit, EF Kruyt, FAE Pinedo, HM van Tinteren, H Giaccone, G
Citation: Cg. Ferreira et al., Expression of X-linked inhibitor of apoptosis as a novel prognostic markerin radically resected non-small cell lung cancer patients, CLIN CANC R, 7(8), 2001, pp. 2468-2474

Authors: Zinda, MJ Johnson, MA Paul, JD Horn, C Konicek, BW Lu, ZH Sandusky, G Thomas, JE Neubauer, BL Lai, MT Graff, JR
Citation: Mj. Zinda et al., AKT-1,-2, and-3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon, CLIN CANC R, 7(8), 2001, pp. 2475-2479

Authors: Mariani, L Beaudry, C McDonough, WS Hoelzinger, DB Kaczmarek, E Ponce, F Coons, SW Giese, A Seiler, RW Berens, ME
Citation: L. Mariani et al., Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro, CLIN CANC R, 7(8), 2001, pp. 2480-2489

Authors: Shan, D Gopal, AK Press, OW
Citation: D. Shan et al., Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells, CLIN CANC R, 7(8), 2001, pp. 2490-2495

Authors: Casado, E Gomez-Navarro, J Yamamoto, M Adachi, Y Coolidge, CJ Arafat, WO Barker, SD Wang, MH Mahasreshti, PJ Hemminki, A Gonzalez-Baron, M Barnes, MN Pustilnik, TB Siegal, GP Alvarez, RD Curiel, DT
Citation: E. Casado et al., Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications, CLIN CANC R, 7(8), 2001, pp. 2496-2504

Authors: Schafer, JM Lee, ES Dardes, RC Bentrem, D O'Regan, RM Reyes, AD Jordan, VC
Citation: Jm. Schafer et al., Analysis of cross-resistance of the selective estrogen receptor modulatorsarzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts, CLIN CANC R, 7(8), 2001, pp. 2505-2512

Authors: Sakamoto, H Mashima, T Sato, S Hashimoto, Y Yamori, T Tsuruo, T
Citation: H. Sakamoto et al., Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells, CLIN CANC R, 7(8), 2001, pp. 2513-2518

Authors: Mohanam, S Jasti, SL Kondraganti, SR Chandrasekar, N Kin, Y Fuller, GN Lakka, SS Kyritsis, AP Dinh, DH Olivero, WC Gujrati, M Yung, WKA Rao, JS
Citation: S. Mohanam et al., Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells, CLIN CANC R, 7(8), 2001, pp. 2519-2526

Authors: Jung, CP Motwani, MV Schwartz, GK
Citation: Cp. Jung et al., Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotidereductase M2 subunit, CLIN CANC R, 7(8), 2001, pp. 2527-2536

Authors: Tortora, G Caputo, R Damiano, V Bianco, R Fontanini, G Cuccato, S De Placido, S Bianco, AR Ciardiello, F
Citation: G. Tortora et al., Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis, CLIN CANC R, 7(8), 2001, pp. 2537-2544

Authors: Chan, TW Pollak, M Huynh, H
Citation: Tw. Chan et al., Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780, CLIN CANC R, 7(8), 2001, pp. 2545-2554

Authors: Jiang, WG Grimshaw, D Lane, J Martin, TA Abounder, R Laterra, J Mansel, RE
Citation: Wg. Jiang et al., A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells, CLIN CANC R, 7(8), 2001, pp. 2555-2562

Authors: Solorzano, CC Baker, CH Tsan, R Traxler, P Cohen, P Buchdunger, E Killion, JJ Fidler, IJ
Citation: Cc. Solorzano et al., Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma, CLIN CANC R, 7(8), 2001, pp. 2563-2572

Authors: Guilbaud, N Kraus-Berthier, L Meyer-Losic, F Malivet, V Chacun, C Jan, M Tillequin, F Michel, S Koch, M Pfeiffer, B Atassi, G Hickman, J Pierre, A
Citation: N. Guilbaud et al., Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors, CLIN CANC R, 7(8), 2001, pp. 2573-2580
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>